International Consolidated Airlines Group. S.A.

AGM Information • Jun 19, 2025

---

date: 2025-06-17 09:04:00+00:00
processor: python-docx+mammoth
status: success

---

INTERNATIONAL CONSOLIDATED AIRLINES GROUP, S.A.

2025 ANNUAL SHAREHOLDERS' MEETING

At the Annual Shareholders´ Meeting held on 19 June 2025, the following resolutions were duly passed:

ANNUAL ACCOUNTS, CORPORATE MANAGEMENT AND AUDITOR

1. Approval of the 2024 financial statements and management reports of the Company and of its consolidated group.

RESOLUTION 1

“To approve the individual annual financial statements and management report of International Consolidated Airlines Group, S.A. and the consolidated annual financial statements and management report of International Consolidated Airlines Group, S.A. and its subsidiaries for the financial year ended 31 December 2024, which were formulated by the Board of Directors at its meeting held on 27 February 2025.”

1. Approval of the consolidated non-financial information statement and sustainability information report for financial year 2024.

RESOLUTION 2

“To approve the non-financial information statement and sustainability information report for financial year 2024 included in the consolidated management report of International Consolidated Airlines Group, S.A. and its subsidiaries for the financial year ended 31 December 2024, which was formulated by the Board of Directors at its meeting held on 27 February 2025.”

1. Approval of the management of the Board of Directors during the 2024 financial year.

RESOLUTION 3

“To approve the management of the Board of Directors during the financial year ended 31 December 2024.”

1. Re-election of KPMG Auditores, S.L. as auditor of the Company and of its consolidated group for financial year 2025 and delegation of powers.

RESOLUTION 4

“To re-elect KPMG Auditores, S.L. as auditor of International Consolidated Airlines Group, S.A. and of its consolidated group to conduct the audit for financial year 2025 and to delegate to the Board of Directors, with the express power of substitution, to enter into the corresponding services agreement with KPMG Auditores, S.L. as auditor, on the terms and conditions and for the remuneration it deems appropriate, and to make such amendments as may be required in accordance with applicable law at any time.”

RESULTS ALLOCATION

1. Approval of the proposal for the allocation of 2024 results.

RESOLUTION 5

“To approve the proposed allocation of the 2024 results of International Consolidated Airlines Group, S.A., consisting of a profit of 941,797 thousand euros, in the following terms:

1. the amount of 147,026 thousand euros to the payment of a dividend that was paid in full prior to this Shareholders’ Meeting as an interim dividend by virtue of the resolution adopted by the Board of Directors at its meeting on 1 August 2024, which it is resolved to ratify to the extent necessary;
2. the amount of 288,000 thousand euros to the payment of a final dividend (corresponding to a fixed dividend of 0.06 euro gross per share to all of the 4,724,163,341 shares outstanding on the date of the call of the Shareholders’ Meeting’s approval) in accordance with Resolution 6 below; and
3. the amount of 506,771 thousand euros (the remainder of the profit for the year following the above distributions) to voluntary reserves.

It is placed on record that the amounts allocated to payment of a final dividend and, consequently, to voluntary reserves have been calculated taking into consideration the number of outstanding shares at the date of approval of the call of the Shareholders’ Meeting.

In the event that the number of shares entitled to receive the final dividend is increased, the total amount allocated to payment of the final dividend shall be increased as a result, and the amount allocated to voluntary reserves shall be reduced accordingly, and vice versa if the number of shares entitled to receive the final dividend is reduced (for example, by an increase in the treasury stock shares).”

1. 2024 Final dividend approval.

RESOLUTION 6

“To distribute a final dividend in cash, out of profit for 2024, of euro 0.06 gross per outstanding share of the Company entitled to receive it on the date on which payment is made.

Payment shall be made from 30 June 2025.

The withholdings required by the applicable legislation from time to time shall be deducted from the gross amounts paid.

For such purposes, to authorise the Board of Directors, on the broadest terms, with the express power of substitution, to adopt all decisions and perform all steps necessary or appropriate, for the payment of the final dividend approved above, including, in particular and without limitation, to establish the terms and conditions of the distribution in all matters not provided for above, to designate the entity or entities that is/are to act as paying agent and sign the relevant contract(s) on the terms and conditions it sees fit, to draw from current accounts for such purpose, to make the appropriate communications and notifications and, in general, to take any other steps that may be necessary or appropriate for the successful completion of the approved distribution.”

DIRECTORS´ RE-ELECTION, APPOINTMENT AND RESOLUTIONS ON DIRECTORS´ REMUNERATION

1. Re-election and appointment of directors for the Corporate Bylaws mandated one-year term:
2. To re-elect Mr. Javier Ferrán as non-executive independent director.

RESOLUTION 7.a)

“To re-elect Mr. Francisco Javier Ferrán Larraz as a director for the bylaw mandated one-year term, upon proposal from the Nominations Committee, with the status of non-executive independent director.”

1. To re-elect Mr. Luis Gallego as Executive Director.

RESOLUTION 7.b)

“To re-elect Mr. Luis Gallego Martín as a director for the bylaw mandated one-year term, upon proposal from the Nominations Committee, with the status of executive director”.

1. To re-elect Ms. Eva Castillo as non-executive independent director.

RESOLUTION 7.c)

“To re-elect Ms. Eva Castillo Sanz as director for the bylaw mandated one-year term, upon proposal from the Nominations Committee, with the status of non-executive independent director.”

1. To re-elect Ms. Margaret Ewing as non-executive independent director.

RESOLUTION 7.d)

“To re-elect Ms. Margaret Ewing as a director for the bylaw mandated one-year term, upon proposal from the Nominations Committee, with the status of non-executive independent director.”

1. To re-elect Mr. Maurice Lam as non-executive independent director.

RESOLUTION 7.e)

“To re-elect Mr. Lam Fat Kwong Lam Thuon Mine (known as Maurice Lam) as director for the bylaw mandated one-year term, upon proposal from the Nominations Committee, with the status of non-executive independent director.”

1. To re-elect Mr Bruno Matheu as non-executive proprietary director.

RESOLUTION 7.f)

“To re-elect Mr Bruno Louis Matheu as a director for the bylaw mandated one-year term, upon favourable report from the Nominations Committee, with the status of non-executive proprietary director.”

1. To re-elect Ms. Heather Ann McSharry as non-executive independent director.

RESOLUTION 7.g)

“To re-elect Ms. Heather Ann McSharry as director for the bylaw mandated one-year term, upon proposal from the Nominations Committee, with the status of non-executive independent director.”

1. To re-elect Mr. Robin Phillips as non-executive proprietary director.

RESOLUTION 7.h)

“To re-elect Mr. Robin Charles Phillips as a director for the bylaw mandated one-year term, upon favourable report from the Nominations Committee, with the status of non-executive proprietary director.”

1. To re-elect Ms Nicola Shaw as non-executive independent director.

RESOLUTION 7.i)

“To re-elect Ms Lucy Nicola Shaw as a director for the bylaw mandated one-year term, upon proposal from the Nominations Committee, with the status of non-executive independent director.”

1. To appoint Ms Simone menne as non-executive independent director.

RESOLUTION 7.j)

“To appoint Ms Simone Menne as a director for the bylaw mandated one-year term, upon proposal from the Nominations Committee, with the status of non-executive independent director.”

1. To appoint Ms Päivi Rekonen as non-executive independent director.

RESOLUTION 7.k)

“To appoint Ms Päivi Rekonen-Fleischer as a director for the bylaw mandated one-year term, upon proposal from the Nominations Committee, with the status of non-executive independent director.”

1. Consultative vote on the 2024 annual report on directors’ remuneration.

RESOLUTION 8

“To approve, on a consultative basis, the 2024 annual report on the remuneration of the directors of International Consolidated Airlines Group, S.A.”

1. Approval of the directors’ remuneration policy.

RESOLUTION 9

“To approve, on a binding basis, the remuneration policy for the directors of International Consolidated Airlines Group, S.A., which includes the introduction and participation of executive directors in a new Stretch Performance Incentive Plan (SPIP) of the Company, that is also approved for all relevant purposes, which will operate under the IAG Executive Share Plan approved by the 2021 Shareholders’ Meeting and as described in the new directors’ remuneration policy.”

CAPITAL REDUCTION

1. Approval of a reduction in share capital by means of the cancellation of up to 426,206,309 shares (8.57 per cent of the share capital). Delegation of powers for the implementation thereof.

RESOLUTION 10

“To reduce the share capital by cancellation of shares of the Company acquired (i) through the €350,000,000 buy-back programme for the cancellation thereof authorised by the Board of Directors at its meeting on 7 November 2024 and announced on 8 November 2024, which finalised on 27 February 2025 (the “November 2024 Buy-back Programme”); and (ii) through the €1,000,000,000 buy-back programme for the cancellation thereof authorised by the Board of Directors at its meeting on 27 February 2025 and announced on 28 February 2025, to be implemented not later than 27 February 2026 (the “February 2025 Buy-back Programme” and, together with the November 2024 Buy-back Programme, the “Buy-back Programmes”), in the following terms:

1.- Amount and form of the capital reduction.- The nominal amount of the capital reduction of the Company will be equal to the number of shares acquired under the Buy-back Programmes multiplied by 0.10 euro per share, through the cancellation of such shares, up to a maximum of 42,620,630.90 euros, through the cancellation of: (i) 96,206,309 shares (1.94 per cent of the share capital of the Company) acquired under the November 2024 Buy-back Programme; plus (ii) up to 330,000,000 shares (6.64 per cent of the share capital of the Company) to be acquired under the February 2025 Buy-back Programme.

In accordance with the provisions below, the final amount of the capital reduction will be determined by the Board of Directors according to the final number of shares acquired through the Buy-back Programmes.

2.- Procedure for acquisition of the shares that will be cancelled under the Buy-back Programmes. - The shares to be cancelled will be those acquired by the Company under the Buy-back Programmes.

It is placed on record that the November 2024 Buy-back Programme finalised on 27 February 2025 and the February 2025 Buy-back Programme will finalise no later than 27 February 2026.

In accordance with the foregoing, pursuant to article 340.3 of the Spanish Companies Law (Ley de Sociedades de Capital), if the Company does not acquire the maximum number of 426,206,309 ordinary shares, each with a nominal value of 0.10 euro, under the Buy-back Programmes, the share capital will be reduced by the number of shares effectively acquired within the framework of the Buy-back Programmes.

3.- Procedure for the reduction and reserves with a charge to which it is carried out.- Pursuant to the provisions of article 342 of the Spanish Companies Law, the capital reduction must be implemented, totally or partially and on one or more occasions, within a period ending at next year’s annual Shareholders’ Meeting (or if earlier, 15 months from the date of passing of this resolution).

The capital reduction does not entail a return of contributions to shareholders because the Company itself is or will be the holder of the shares being cancelled, and it will be carried out with a charge to unrestricted reserves by funding a retired capital reserve in an amount equal to the nominal value of the cancelled shares; such reserve may only be used by complying with the same requirements as those applicable to a reduction in share capital, as provided by article 335 c) of the Spanish Companies Law.

Therefore, in accordance with the provisions of such article, creditors of the Company will not be entitled to assert the right of objection contemplated by article 334 of the Spanish Companies Law in connection with the capital reduction.

4.- Delegation of powers.- To delegate to the Board of Directors, with express powers of substitution, the powers necessary to implement this resolution within a period ending at next year’s annual Shareholders’ Meeting (or if earlier, 15 months from the date of passing of this resolution), with authority to establish any terms that are not expressly set forth in this resolution or that are a consequence hereof. In particular, and by way of example only, the following powers are delegated to the Board of Directors, with express powers of substitution:

1. To perform any acts, make any statements, or take any steps that may be required in connection with the successful completion of the Buy-back Programme and the capital reduction.
2. To declare the approved capital reduction to be completed and implemented, totally or partially and in one or more occasions, establishing, for such purpose, the final number of shares that must be cancelled each time and, as a result, the amount by which the share capital of the Company must be reduced in accordance with the rules specified in this resolution.
3. To set the final amount of the capital reduction based on the provisions of this resolution and establish any other terms that may be required to implement it, all in accordance with the terms and conditions set forth above.
4. To amend the article of the By-Laws setting the share capital such that it reflects the amount of share capital and the number of outstanding shares resulting from the implementation of the capital reduction.
5. To take such steps and carry out such formalities as may be required or appropriate and submit such documents as may be necessary to the competent bodies such that, once the shares of the Company have been cancelled and the notarial instrument for the capital reduction has been executed and registered with the Commercial Registry, the cancelled shares are delisted from the relevant stock exchanges and are removed from the corresponding book-entry registers.
6. To perform all acts that may be necessary or appropriate to implement and formalise the capital reduction before any Spanish or foreign public or private entities and agencies, including acts for purposes of representation, supplementation, or correction of defects or omissions that might prevent or hinder the full effectiveness of the foregoing resolutions.

Pursuant to the provisions of article 249.2 of the Spanish Companies Law, the Board of Directors is expressly authorised to further delegate the powers referred to in this resolution.”

AUTHORISATIONS FOR THE ACQUISITION OF OWN SHARES, FOR THE ISSUANCE OF SHARES AND CONVERTIBLE OR EXCHANGEABLE SECURITIES AND FOR THE EXCLUSION OF PRE-EMPTIVE RIGHTS

1. Authorisation for the derivative acquisition of the Company’s own shares by the Company itself and/or by its subsidiaries.

RESOLUTION 11

“To authorise the derivative acquisition of shares of International Consolidated Airlines Group, S.A. within the scope of article 146 of the Spanish Companies Law (Ley de Sociedades de Capital), complying with the applicable legislation and subject to the following conditions:

1. The acquisitions may be made directly by International Consolidated Airlines Group, S.A. or indirectly through its subsidiaries, on the same terms resulting from this resolution.
2. The acquisitions shall be made through purchase and sale, exchange or any other transaction permitted by the law.
3. The maximum aggregate number of shares which are authorised to be purchased is the lower of the maximum amount permitted by the law and the number as represents 10 per cent of the share capital as at the date of passing this resolution.
4. The minimum price which may be paid for a share is zero;
5. The maximum price which may be paid for a share is the highest of:
6. an amount equal to five per cent above the average of the middle market quotations for the shares as taken from the relevant stock exchange for the five business days immediately preceding the day on which the transaction is performed; and
7. the higher of the price of the last independent trade and the highest current independent bid on the trading venues where the transaction is carried out at the relevant time;

in each case, exclusive of expenses.

1. The authorisation is granted for a term ending at next year’s annual Shareholders’ Meeting (or if earlier, 15 months from the date of passing of this resolution).

For the purposes of Article 146 of the Spanish Companies Law, it is expressly stated that the shares acquired pursuant to this authorisation may be delivered directly to the employees or directors of the Company or its subsidiaries or as a result of the exercise of option rights held thereby.”

1. Authorisation to the Board of Directors, with the express power of substitution, to increase the share capital pursuant to the provisions of Article 297.1.b) of the Companies Law.

RESOLUTION 12

“To authorise the Board of Directors, to the fullest extent required under applicable law, with express power of substitution, and in accordance with Article 297.1.b) of the Spanish Companies Law (Ley de Sociedades de Capital), to increase the share capital of the Company on one or more occasions and when required, through the issuance and placement into circulation of new shares (with or without a premium) the consideration for which shall be cash contributions, under the following terms:

1. Term of the authorisation.- The capital increases subject to this authorisation may be done within a term ending at next year’s annual Shareholders’ Meeting (or, if earlier, 15 months from the date of passing of this resolution).
2. Maximum amount authorised.- The aggregate maximum amount of the issuance or issuances of ordinary shares shall be 50 per cent of the share capital on the date of passing this resolution (such amount to be reduced by the maximum amount that the share capital may need to be increased on the conversion or exchange of any securities issued under resolution 13).
3. Scope of the authorisation.- The Board of Directors may establish, as to all matters not otherwise contemplated, the terms and conditions of the share capital increase and may also freely offer the new shares that are not subscribed for within the period or periods for the exercise of pre-emptive rights. The Board of Directors may also resolve that, in the event of incomplete subscription, the share capital shall be increased only by the amount of the subscriptions made and amend the article of the bylaws relating to share capital and number of shares.
4. Admission to listing.- The Company shall, when appropriate, apply for listing on regulated markets, multilateral trading systems or other secondary markets, organised or otherwise, official or unofficial, Spanish or foreign, of the shares issued under this authorisation and the Board of Directors shall be authorised to carry out all acts and formalities that may be required for admission to listing with the appropriate authorities of the various Spanish or foreign securities markets.
5. Power of delegation.- The Board of Directors is expressly authorised to delegate the powers sub-delegated thereto under this resolution, as permitted by Article 249.bis l) of the Spanish Companies Law.”
6. Authorisation to the Board of Directors, with the express power of substitution, to issue securities (including warrants) convertible into and/or exchangeable for shares of the Company. Establishment of the criteria for determining the basis for and the terms and conditions applicable to the conversion or exchange.

RESOLUTION 13

“To authorise the Board of Directors, with the express power of substitution, pursuant to the general provisions governing the issuance of debentures and the provisions of Articles 286, 297 and 511 of the Spanish Companies Law (Ley de Sociedades de Capital) and Article 319 of the Regulations of the Mercantile Registry (Reglamento del Registro Mercantil), to issue securities under the following terms:

1. Securities to be issued. - The securities contemplated in this authorisation may be debentures, bonds and other debt securities that are exchangeable for shares of the Company and/or convertible into shares of the Company, as well as warrants (options to subscribe for new shares of the Company or to acquire existing shares of the Company).
2. Term of the authorisation.- The securities subject to this authorisation may be issued on one or more occasions and when required, within the term ending at next year’s annual Shareholders’ Meeting (or, if earlier, 15 months from the date of passing of this resolution).
3. Maximum amount authorised.- The maximum aggregate nominal amount of the issuance or issuances of securities approved under this delegation shall be 1,500,000,000 euros or the equivalent thereof in another currency, provided that the aggregate share capital that may need to be increased on the conversion or exchange of all such securities may not be higher than 50 per cent of the share capital as at the date of passing this resolution (such amount to be reduced by the amount that the share capital has been increased under resolution 12).
4. Scope of authorisation.- This authorisation extends as broadly as is required under law, to the establishment of the various terms and conditions of each issuance. By way of example and not of limitation, the Board of Directors shall be authorised to do the following with respect to each issuance: determine the amount thereof, always within the aforementioned overall quantitative limit; the place of issuance (in Spain or abroad); the domestic or foreign currency, and in the case of a foreign currency, its equivalence in euros; the name or form of the securities, whether they be bonds or debentures, including subordinated debentures, warrants (which may in turn be settled by means of the physical delivery of the shares or, if applicable, through the payment of differences in price), or any other name or form permitted by law; the date or dates of issuance; the number of securities and the par value thereof, which, in the case of convertible and/or exchangeable bonds or debentures, shall not be less than the par value of the shares; in the case of warrants and similar securities, the issue price and/or premium, the exercise price (which may be fixed or variable) and the procedure, period and other terms and conditions applicable to the exercise of the right to subscribe for the underlying shares or, if applicable, the exclusion of such right; the interest rate (whether fixed or variable), and the dates and procedures for payment of the coupon; whether the issuance is perpetual or subject to repayment and, in the latter case, the repayment period and the maturity date or dates; guarantees, reimbursement rate, premiums and lots; the form of representation, as securities or book entries; anti-dilution provisions; the rules applicable to subscription; the rank of the securities and the subordination clauses, if any; the law applicable to the issuance; the power to make application, where appropriate, for the listing of the securities to be issued on Spanish or foreign, official or unofficial, organised or other secondary markets, subject to the requirements established by applicable regulations in each case; and, in general, any other terms of the issuance as well as, if applicable, the appointment of the security-holders’ syndicate representative (comisario) and the approval of the basic rules that are to govern the legal relationships between the Company and the syndicate of holders of the securities to be issued, in the event that such syndicate must or is decided to be created.
5. Basis for and terms and conditions applicable to the conversion and/or exchange.- In the case of issuance of convertible and/or exchangeable debentures or bonds, and for purposes of determining the basis for and the terms and conditions applicable to the conversion and/or exchange, it is resolved to establish the following criteria:
6. The securities issued pursuant to this resolution shall be convertible into shares of the Company and/or exchangeable into shares of the Company, in accordance with a fixed or variable conversion and/or exchange ratio determined or to be determined, with the Board of Directors being authorised to decide whether they are convertible and/or exchangeable, as well as to determine whether they are mandatorily or voluntarily convertible and/or exchangeable, and if voluntarily, at the option of the holder thereof and/or of the Company, at the intervals and during the period established in the resolution providing for the issuance.
7. In the event that the issuance is convertible and exchangeable, the Board may also provide that the issuer reserves the right at any time to elect between conversion into new shares or the exchange thereof for outstanding shares of the Company, with the nature of the shares to be delivered being determined at the time of conversion or exchange, and may also elect to deliver a combination of newly-issued shares and existing shares of the Company and even to settle the difference in cash.
8. For purposes of the conversion and/or exchange, the securities shall be valued at the nominal amount thereof (including, should it be the case, accrued and not paid interests), and the shares at the fixed exchange ratio established in the resolution of the Board of Directors whereby this authorisation is exercised, or at a variable ratio to be determined on the date or dates specified in such resolution of the Board, based on the listing price of the Company’s shares on the date(s) or during the period(s) used as a reference in such resolution, at a premium or at a discount, provided, however, that if a discount is established on the price per share, it shall not be greater than 25 per cent of the value of the shares used as a reference value as set forth above.
9. In no event may the value of the share for purposes of the ratio for conversion of debentures into shares be less than the par value thereof. In addition, pursuant to the provisions of Article 415 of the Spanish Companies Law, debentures may not be converted into shares when the nominal value of the former is less than the par value of the latter.
10. Basis and terms and conditions for the exercise of warrants.- In the case of issuances of warrants, to which the provisions of the Spanish Companies Law on convertible debentures shall apply by analogy, the Board of Directors is authorised to determine, in the broadest terms, in connection with the basis for and the terms and conditions applicable to the exercise of such warrants, the criteria applicable to the exercise of rights to subscribe for or of rights to acquire shares of the Company arising from the securities of this kind issued under the delegation granted hereby. The criteria set forth in section 5 above shall apply to such issuances, with such adjustments as may be necessary in order to bring them into compliance with the legal and financial rules governing these kinds of securities.
11. Other powers delegated.- This authorisation to the Board of Directors also includes, without limitation, the delegation thereto of the following powers:
12. The power to increase the share capital to the extent required to exercise requests for conversion and/or for exercise of the right to subscribe for new shares. These powers may only be exercised so long as the capital increase the Board of Directors approves for the issue of convertible securities or warrants does not exceed the unused limit authorised in each moment by the Shareholders’ Meeting in accordance with Article 297.1.b) of the Spanish Companies Law. This authorisation to increase the share capital includes the authorisation to issue and float, on one or more occasions, the shares representing such capital that are necessary to carry out the conversion and/or to exercise the right to subscribe for new shares, as well as the power to amend the article of the bylaws relating to the amount of the share capital and the number of shares and, if appropriate, to cancel the portion of such capital increase that was not required for the conversion of shares and/or the exercise of the right to subscribe for new shares.
13. The power to elaborate on and specify the basis for and the terms and conditions applicable to the conversion, exchange and/or exercise of the rights to subscribe for and/or acquire shares arising from the securities to be issued, taking into account the criteria set out in sections 5 and 6 above.
14. The delegation to the Board of Directors includes the broadest powers that may be required by law in order to interpret, apply, implement and develop the resolutions providing for the issuance of securities that are convertible into or exchangeable for shares of the Company, on one or more occasions, and to carry out the corresponding capital increase, as well as the power to correct and supplement such resolutions as to all matters that may be necessary and to comply with all legal requirements for the successful implementation thereof. To such end, the Board of Directors may correct any omissions or defects in the aforementioned resolutions that may be identified by any Spanish or foreign authorities, officers or bodies, and may also adopt all such resolutions and execute all such public or private documents as it may deem necessary or appropriate in order to adjust the preceding resolutions for the issuance of convertible or exchangeable securities and the corresponding capital increase to the oral or written assessment of the Commercial Registrar or, in general, of any other Spanish or foreign competent authorities, officers or entities.
15. Admission to trading.- The Company shall, where appropriate, apply for listing on regulated markets, multilateral trading systems or other secondary markets, organised or otherwise, official or unofficial, Spanish or foreign of the securities issued by the Company under this delegation, and the Board of Directors is authorised, as fully as is required by law, to conduct all acts and formalities that may be necessary for admission to listing before the appropriate authorities of the various Spanish or foreign securities markets.
16. Guarantee of issues of convertible and/or exchangeable securities or warrants by subsidiaries.- The Board of Directors is also authorised to guarantee on behalf of the Company, within the limits set forth above, new issuances of convertible and/or exchangeable securities or warrants by subsidiaries during the effective period of this resolution.
17. Power to delegate.- The Board of Directors is expressly authorised to sub-delegate the powers delegated thereto under this resolution, as permitted by Article 249 bis l) of the Spanish Companies Law.”
18. Authorisation to the Board of Directors, with the express power of substitution, to exclude pre-emptive rights in connection with the capital increases and the issuances of convertible or exchangeable securities that the Board of Directors may approve under the authorities given under Resolutions 12 and 13:

RESOLUTION 14

1. Up to 10 per cent of the share capital on an unrestricted basis.

RESOLUTION 14.a)

“To authorise the Board of Directors, with the express power of substitution, to totally or partially exclude the pre-emptive right, as permitted by Article 506 and Article 511 of the Spanish Companies Law (Ley de Sociedades de Capital) in connection with issuances of shares or convertible or exchangeable securities that the Board of Directors may approve under the authority given under resolutions 12 and 13 above provided that such capital increases and issuances of convertible or exchangeable securities are subject to an aggregate maximum nominal amount of the shares so allotted and that may be allotted on conversion or exchange of such securities of 10 per cent of the Company’s share capital (excluding any shares held in treasury) as at the date of passing this resolution.

The Board of Directors is expressly authorised to sub-delegate the powers delegated thereto under this resolution, as permitted by Article 249 bis l) of the Spanish Companies Law.”

1. Up to an additional 10 per cent of the share capital to be used for either an acquisition or a specified capital investment.

RESOLUTION 14.b)

“In addition to the authority given to the Board of Directors under resolution 14.a) above, to authorise the Board of Directors, with the express power of substitution, to totally or partially exclude the pre-emptive right, as permitted by Article 506 and Article 511 of the Spanish Companies Law (Ley de Sociedades de Capital) in connection with issuances of shares or convertible or exchangeable securities that the Board of Directors may approve under the authority given under resolutions 12 and 13 above, provided that such capital increases and issuances of convertible or exchangeable securities are subject to an aggregate maximum nominal amount of the shares so allotted and that may be allotted on conversion or exchange of such securities of 10 per cent of the Company’s share capital (excluding any shares held in treasury) as at the date of passing this resolution; such authority to be used only for the purposes of financing (or refinancing, if the authority is to be used within 12 months after the original transaction) a transaction which the Board of the Company determines to be either an acquisition or a specified capital investment.

The Board of Directors is expressly authorised to sub-delegate the powers delegated thereto under this resolution, as permitted by Article 249 bis l) of the Spanish Companies Law.”

AIRCRAFT PURCHASES

1. approval of the proposed purchase of 21 airbus a330-900neo family aircraft and 32 boeing 787-10 family aircraft.

RESOLUTION 15

“To authorise, for the purposes of article 160(f) of the Spanish Companies Law (Ley de Sociedades de Capital), the acquisition of 21 Airbus A330-900neo family aircraft and 32 Boeing 787-10 family aircraft (including engines and rights to purchase additional aircraft) by International Consolidated Airlines Group, S.A. and/or any of its subsidiaries, on substantially the same terms and conditions described in the Board of Directors’ report issued in relation to such transaction dated 8 May 2025.”

DELEGATION OF POWERS

1. Delegation of powers to formalise and execute all resolutions adopted by the Shareholders’ Meeting.

RESOLUTION 16

“Without prejudice to the powers delegated in the preceding resolutions, to confer authority on the Board of Directors, with the express power of substitution, to the Chairman of the Board of Directors, to the Senior Independent Director, to the Chief Executive Officer, to the Secretary of the Board of Directors and to the Deputy Secretary of the Board of Directors, to the fullest extent permitted by law, so that any of them may execute the foregoing resolutions, for which purpose they may: (i) establish, interpret, clarify, complete, develop, amend, remedy errors or omissions and adapt the aforementioned resolutions according to the verbal or written qualifications of the Mercantile Registry and any competent authorities, civil servants or institutions; (ii) draw up and publish the announcements required by law; (iii) place the aforementioned resolutions on public record and grant any public and/or private documents they deem necessary or advisable for their implementation; (iv) deposit the annual accounts and other mandatory documentation at the Mercantile Registry or in other applicable registries, and (v) engage in any acts that may be necessary or advisable to successfully implement them and, in particular, to have them filed at the Mercantile Registry or in other applicable registries.”

* * *

19 June 2025